Annual CFF
$7.08 M
-$72.54 M-91.11%
30 June 2022
Summary:
Applied Genetic Technologies annual cash flow from financing activities is currently $7.08 million, with the most recent change of -$72.54 million (-91.11%) on 30 June 2022. During the last 3 years, it has fallen by -$72.54 million (-91.11%).AGTC Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$7.14 M
+$9.50 M+401.78%
30 September 2022
Summary:
Applied Genetic Technologies quarterly cash flow from financing activities is currently $7.14 million, with the most recent change of +$9.50 million (+401.78%) on 30 September 2022.AGTC Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$14.20 M
+$7.12 M+100.66%
30 September 2022
Summary:
Applied Genetic Technologies TTM cash flow from financing activities is currently $14.20 million, with the most recent change of +$7.12 million (+100.66%) on 30 September 2022.AGTC TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AGTC Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -91.1% | +10000.0% | -82.2% |
| 5 y5 years | +10000.0% | +10000.0% | +6535.1% |
AGTC Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -91.1% | -89.8% | -85.0% |
Applied Genetic Technologies Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | $7.14 M(-401.8%) | $14.20 M(+100.7%) |
| June 2022 | $7.08 M(-91.1%) | -$2.37 M(-125.5%) | $7.08 M(-63.5%) |
| Mar 2022 | - | $9.28 M(+6084.7%) | $19.41 M(-75.7%) |
| Dec 2021 | - | $150.00 K(+971.4%) | $79.85 M(+0.0%) |
| Sept 2021 | - | $14.00 K(-99.9%) | $79.85 M(+0.3%) |
| June 2021 | $79.61 M(+77.0%) | $9.97 M(-85.7%) | $79.61 M(+0.3%) |
| Mar 2021 | - | $69.72 M(>+9900.0%) | $79.40 M(+76.8%) |
| Dec 2020 | - | $146.00 K(-166.4%) | $44.90 M(+0.4%) |
| Sept 2020 | - | -$220.00 K(-102.3%) | $44.74 M(-0.5%) |
| June 2020 | $44.98 M(>+9900.0%) | $9.75 M(-72.3%) | $44.98 M(+27.1%) |
| Mar 2020 | - | $35.22 M(<-9900.0%) | $35.40 M(>+9900.0%) |
| Dec 2019 | - | -$11.00 K(-155.0%) | $135.00 K(-36.9%) |
| Sept 2019 | - | $20.00 K(-88.0%) | $214.00 K(+214.7%) |
| June 2019 | $68.00 K(-150.0%) | $167.00 K(-507.3%) | $68.00 K(-136.0%) |
| Mar 2019 | - | -$41.00 K(-160.3%) | -$189.00 K(+5.6%) |
| Dec 2018 | - | $68.00 K(-154.0%) | -$179.00 K(-32.2%) |
| Sept 2018 | - | -$126.00 K(+40.0%) | -$264.00 K(+94.1%) |
| June 2018 | -$136.00 K(-585.7%) | -$90.00 K(+190.3%) | -$136.00 K(+202.2%) |
| Mar 2018 | - | -$31.00 K(+82.4%) | -$45.00 K(+309.1%) |
| Dec 2017 | - | -$17.00 K(-950.0%) | -$11.00 K(-200.0%) |
| Sept 2017 | - | $2000.00(+100.0%) | $11.00 K(-60.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2017 | $28.00 K(-99.9%) | $1000.00(-66.7%) | $28.00 K(-62.7%) |
| Mar 2017 | - | $3000.00(-40.0%) | $75.00 K(+4.2%) |
| Dec 2016 | - | $5000.00(-73.7%) | $72.00 K(-76.2%) |
| Sept 2016 | - | $19.00 K(-60.4%) | $302.00 K(-98.5%) |
| June 2016 | $19.49 M(-39.4%) | $48.00 K(>+9900.0%) | $19.49 M(+0.2%) |
| Mar 2016 | - | $0.00(-100.0%) | $19.45 M(-0.4%) |
| Dec 2015 | - | $235.00 K(-98.8%) | $19.52 M(+1.0%) |
| Sept 2015 | - | $19.21 M(>+9900.0%) | $19.33 M(-39.9%) |
| June 2015 | $32.16 M(-48.5%) | $0.00(-100.0%) | $32.16 M(-61.6%) |
| Mar 2015 | - | $79.00 K(+102.6%) | $83.76 M(-0.1%) |
| Dec 2014 | - | $39.00 K(-99.9%) | $83.88 M(-11.3%) |
| Sept 2014 | - | $32.04 M(-37.9%) | $94.52 M(+51.3%) |
| June 2014 | $62.48 M(+146.2%) | $51.61 M(>+9900.0%) | $62.48 M(+119.9%) |
| Mar 2014 | - | $194.00 K(-98.2%) | $28.42 M(+1.1%) |
| Dec 2013 | - | $10.68 M(>+9900.0%) | $28.10 M(+12.8%) |
| Sept 2013 | - | $0.00(-100.0%) | $24.92 M(-1.8%) |
| June 2013 | $25.38 M(+5843.1%) | $17.54 M(<-9900.0%) | $25.38 M(+223.8%) |
| Mar 2013 | - | -$118.00 K(-101.6%) | $7.84 M(-1.5%) |
| Dec 2012 | - | $7.50 M(+1552.4%) | $7.96 M(+1652.4%) |
| Sept 2012 | - | $454.00 K | $454.00 K |
| June 2012 | $427.00 K | - | - |
FAQ
- What is Applied Genetic Technologies annual cash flow from financing activities?
- What is the all time high annual CFF for Applied Genetic Technologies?
- What is Applied Genetic Technologies quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Applied Genetic Technologies?
- What is Applied Genetic Technologies TTM cash flow from financing activities?
- What is the all time high TTM CFF for Applied Genetic Technologies?
What is Applied Genetic Technologies annual cash flow from financing activities?
The current annual CFF of AGTC is $7.08 M
What is the all time high annual CFF for Applied Genetic Technologies?
Applied Genetic Technologies all-time high annual cash flow from financing activities is $79.61 M
What is Applied Genetic Technologies quarterly cash flow from financing activities?
The current quarterly CFF of AGTC is $7.14 M
What is the all time high quarterly CFF for Applied Genetic Technologies?
Applied Genetic Technologies all-time high quarterly cash flow from financing activities is $69.72 M
What is Applied Genetic Technologies TTM cash flow from financing activities?
The current TTM CFF of AGTC is $14.20 M
What is the all time high TTM CFF for Applied Genetic Technologies?
Applied Genetic Technologies all-time high TTM cash flow from financing activities is $94.52 M